Septerna (SEPN) Retained Earnings (2023 - 2026)
Septerna (SEPN) recorded quarterly Retained Earnings of -$569000.0 in Q1 2026, up 99.66% quarter-over-quarter from -$167.3 million in Q4 2025, and up 99.59% on a YoY basis from -$285079.9 in Q1 2025.
Septerna (SEPN) Retained Earnings (2023 - 2026) Analysis & Trends
Septerna's Retained Earnings history runs 4 years deep, the most recent figure standing at -$569000.0 for Q1 2026.
- In Q1 2026, Retained Earnings rose 99.59% year-over-year to -$569000.0; the TTM figure through Mar 2026 stood at -$569000.0 (up 99.59% YoY), while the FY2025 annual figure was -$167.3 million, down 41.29% from the prior year.
- Retained Earnings was -$569000.0 for Q1 2026 at Septerna, up from -$167.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $375000.0 in Q3 2025 to a low of -$167.3 million in Q4 2025.
- Historically, Retained Earnings has averaged -$91.8 million across 4 years, with a median of -$108.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 154.15% in 2024, then jumped 100.38% in 2025.
- A 4-year view of Retained Earnings shows it stood at -$46.6 million in 2023, then plunged by 154.15% to -$118.4 million in 2024, then slumped by 41.29% to -$167.3 million in 2025, then soared by 99.66% to -$569000.0 in 2026.
- The last three Retained Earnings figures came in at -$569000.0 (Q1 2026), -$167.3 million (Q4 2025), and $375000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -569,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -569,000.00 |
| Dec 31, 2025 | -167.25 Mn |
| Sep 30, 2025 | 375,000.00 |
| Jun 30, 2025 | -164.69 Mn |
| Mar 31, 2025 | -139.85 Mn |
| Dec 31, 2024 | -118.37 Mn |
| Sep 30, 2024 | -97.70 Mn |
| Dec 31, 2023 | -46.58 Mn |